Select for export Psilocybin to Manage Cancer-Related Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2016-12-20 Bobby Lazzara OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Review Article More
Select for export Psilocybin for anxiety and depression in cancer care? Lessons from the past and prospects for the future. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675754 PubMed 27909163 Copy citation Copy BibTeX Unknown journal 2016-11-30 Nutt D. Europe PMC Published psilocybin DepressionAnxiety Other More
Select for export Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675512 PubMed 27909164 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116675513 PubMed 27909165 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-30 Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Clinical Trial More
Select for export Psilocybin for depression and anxiety associated with life-threatening illnesses. No abstract availability was recorded for this entry. Details DOI 10.1177/0269881116675771 PubMed 27909171 Copy citation Copy BibTeX Unknown journal 2016-11-30 McCorvy JD, Olsen RH, Roth BL. Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Other More
Select for export The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881116678781 PubMed 27856683 Copy citation Copy BibTeX Journal of Psychopharmacology 2016-11-16 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. Europe PMC Published psilocybin DepressionAnxietyConsciousness Case Report More
Select for export Role of psilocybin in the treatment of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316676092 PubMed 28101325 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2016-10-26 Mahapatra A, Gupta R. Europe PMC Published psilocybin DepressionAnxietyReceptor Pharmacology Other More
Select for export Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3928/02793695-20160616-09 PubMed 27362381 Copy citation Copy BibTeX Journal of Psychosocial Nursing and Mental Health Services 2016-06-30 Howland RH. Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export A Phenomenological Examination of Psilocybin and its Positive and Persisting Aftereffects Abstract available at the source but not redistributed here. Read at source. Details DOI 10.14704/nq.2016.14.2.943 Copy citation Copy BibTeX NeuroQuantology 2016-05-23 Joseph A. Zamaria OpenAlex Published psilocybin DepressionAnxietyOCD Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(15)00576-3 PubMed 27067625 Copy citation Copy BibTeX Unknown journal 2016-04-04 Mithoefer MC, Grob CS, Brewerton TD. Europe PMC Published psilocybin AnxietyPTSDAddiction Randomized Controlled Trial More
Select for export Psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1124/pr.115.011478 PubMed 26841800 Copy citation Copy BibTeX Unknown journal 2016-03-31 Nichols DE. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/zeb.2016.1251 PubMed 27002655 Copy citation Copy BibTeX Unknown journal 2016-03-21 Kyzar EJ, Kalueff AV. Europe PMC Published psilocybin DepressionAnxietyPTSD Animal Study More
Select for export Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125316638008 PubMed 27354908 Copy citation Copy BibTeX Unknown journal 2016-03-17 Dos Santos RG, Osório FL, Crippa JA, Riba J, Zuardi AW, Hallak JE. Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteers No abstract availability was recorded for this entry. Details DOI 10.1016/s0924-977x(15)30364-3 Copy citation Copy BibTeX European Neuropsychopharmacology 2015-08-31 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, Milan Scheidegger, I. Dziobek, Philipp Stämpfli OpenAlex Published psilocybin DepressionAnxietyChronic Pain Other More
Select for export The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nicl.2015.08.009 PubMed 26909323 Copy citation Copy BibTeX NeuroImage Clinical 2015-08-21 Kraehenmann R, Schmidt A, Friston K, Preller KH, Seifritz E, Vollenweider FX. Europe PMC Published psilocybin AnxietyBrain ImagingMechanism of Action Other More
Select for export Psychedelics not linked to mental health problems or suicidal behavior: a population study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568039 PubMed 25744618 Copy citation Copy BibTeX Journal of Psychopharmacology 2015-03-04 Johansen PØ, Krebs TS. Europe PMC Published psilocybin DepressionAnxietyAddiction Other More
Select for export The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-making Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(15)30017-1 Copy citation Copy BibTeX European Psychiatry 2015-02-28 Katrin H. Preller, Thomas Pokorny, Rainer Krähenmann, I. Dziobek, Philipp Stämpfli, F.X. Vollenweider OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568040 PubMed 25670401 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Majić T, Schmidt TT, Gallinat J PubMed Published psilocybin AnxietyAddictionOCD Clinical Trial More
Select for export Psilocybin and Obsessive Compulsive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2014.963754 PubMed 25364991 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2014-10-31 Wilcox JA. Europe PMC Published psilocybin AnxietyOCDReceptor Pharmacology Other More
Psilocybin-Research.com
Searchable psilocybin and psilocin bibliometric database.